| Date Filed | Type | Description |
| 10/03/2023 |
4
| Alder Matthias (CEO) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Exercised 825 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Alder Matthias (CEO) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2022 |
3
| Fuggetta Gianluca (Principal Accounting Officer) has filed a Form 3 on Gain Therapeutics, Inc. |
| 09/22/2022 |
4
| RICHMAN ERIC I (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 329,400 options to buy
@ $3.5, valued at
$1.2M
Granted 54,900 restricted stock units
@ $0 |
|
| 09/22/2022 |
4
| Islam Khalid (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
| 09/22/2022 |
4
| Riley Jeffrey Scott (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
| 09/22/2022 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
| 09/22/2022 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
| 09/22/2022 |
4
| Nicaise Claude (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
| 09/22/2022 |
4
| HASLER HANS PETER (Director) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
| 09/22/2022 |
4
| Alder Matthias (COO) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Granted 60,900 options to buy
@ $3.5, valued at
$213.2k
Granted 10,200 restricted stock units
@ $0 |
|
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| RICHMAN ERIC I (CEO) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Bought 2,482 shares
@ $2.58, valued at
$6.4k
|
|
| 05/23/2022 |
4
| RICHMAN ERIC I (CEO) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Bought 4,000 shares
@ $2.71, valued at
$10.8k
Bought 9,256 shares
@ $2.83, valued at
$26.2k
|
|
| 05/23/2022 |
4/A
| Calabrese Salvatore (CFO) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Bought 3,000 shares
@ $2.7, valued at
$8.1k
|
|
| 04/21/2022 |
4/A
| RICHMAN ERIC I (CEO) has filed a Form 4 on Gain Therapeutics, Inc.|
Txns:
| Bought 4,922 shares
@ $7.866, valued at
$38.7k
|
|
| 04/21/2022 |
3/A
| RICHMAN ERIC I (CEO) has filed a Form 3/A on Gain Therapeutics, Inc. |
| 12/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2021 |
3
| Bellotto Manolo (President and General Manager) has filed a Form 3 on Gain Therapeutics, Inc. |
| 03/29/2021 |
3
| Calabrese Salvatore (CFO) has filed a Form 3 on Gain Therapeutics, Inc. |
| 03/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/17/2021 |
3
| GOLDSTEIN DOV A MD (Director) has filed a Form 3 on Gain Therapeutics, Inc. |